# OnCo record ascendo-biotechnology (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/ascendo-biotechnology/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "ascendo-biotechnology" ;
  schema:name "Ascendo Biotechnology"@en ;
  schema:alternateName "Ascendo Biotechnology Inc."@en, "先知生物科技"@en ;
  schema:description "Ascendo Biotechnology makes an antibody that releases a brake on the body's first-line immune cells, aiming to help the immune system attack solid tumours that resist current immunotherapy."@en ;
  schema:url <https://onco.cc/companies/ascendo-biotechnology/>, <https://www.ascendobiotech.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.ascendobiotech.com/>, <https://www.ascendobiotech.com/2026/05/08/ascendo-biotechnology-completes-oversubscribed-series-a-financing-to-advance-innate-immune-checkpoint-pipeline/>, <https://clinicaltrials.gov/study/NCT06235437> ;
  schema:addressCountry "TW" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:targets <https://onco.cc/targets/cd11b/> .